LPL and chronic kidney disease: Increased levels of PCSK9 levels in patients on statin treatment could indicate a possible implication of PCSK9 in the lipoprotein TG contents by lipoprotein lipase regulation in CKD patients and an effect on high cardiovascular burden in this patient population.